According to our (Global Info Research) latest study, the global Small Molecule Drug Discovery market size was valued at US$ 13330 million in 2025 and is forecast to a readjusted size of US$ 18420 million by 2032 with a CAGR of 4.8% during review period.
The process of small molecule drug discovery can be complex and challenging.Small-molecule drugs are organic compounds affecting molecular pathways by targeting important proteins, which have a low molecular weight, making them penetrate cells easily. Small-molecule drugs can be developed from leads derived from rational drug design or isolated from natural resources.
The global small molecule drug discovery market refers to the pharmaceutical industry’s efforts to discover and develop new drugs based on small organic molecules. Small molecule drugs are chemical compounds with relatively low molecular weight that can interact with specific targets in the body to produce a therapeutic effect.
The market for small molecule drug discovery is driven by the increasing demand for novel and effective drugs to treat various diseases, including cancer, cardiovascular disorders, infectious diseases, and neurological disorders. This market encompasses a wide range of activities, including target identification, hit identification and hit-to-lead optimization, lead optimization, preclinical development, and clinical trials.
Several factors contribute to the growth of this market, such as advancements in drug screening technologies, increased understanding of disease mechanisms, and the availability of genomic and proteomic data. Additionally, the rising prevalence of chronic diseases, population aging, and the need for personalized medicine are also driving the demand for small molecule drug discovery.
The market is highly competitive, with numerous pharmaceutical and biotechnology companies, as well as academic research institutions, involved in drug discovery efforts. These organizations invest significant resources in research and development to identify and develop innovative small molecule drugs.
This report is a detailed and comprehensive analysis for global Small Molecule Drug Discovery market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Small Molecule Drug Discovery market size and forecasts, in consumption value ($ Million), 2021-2032
Global Small Molecule Drug Discovery market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Small Molecule Drug Discovery market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Small Molecule Drug Discovery market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Small Molecule Drug Discovery
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Small Molecule Drug Discovery market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Johnson and Johnson Services, Inc., Teva Pharmaceutical Industries Ltd, Boehringer Ingelheim International GmbH, Allergan Plc., Pfizer Inc., Bristol-Myers Squibb Company, Merck & Co., Inc, GlaxoSmithKline plc., AstraZeneca, Gilead Sciences, Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Small Molecule Drug Discovery market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Target Discovery
Target Validation
Lead Generation
Refinement
Preclinical Development
Others
Market segment by Application
Oncology
Central Nervous System
Cardiovascular
Respiratory
Orthopedics
Immunology
Rare Diseases
Other
Market segment by players, this report covers
Johnson and Johnson Services, Inc.
Teva Pharmaceutical Industries Ltd
Boehringer Ingelheim International GmbH
Allergan Plc.
Pfizer Inc.
Bristol-Myers Squibb Company
Merck & Co., Inc
GlaxoSmithKline plc.
AstraZeneca
Gilead Sciences, Inc.
Novartis AG
Johnson & Johnson
Roche Holding AG
AstraZeneca PLC
Sanofi
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Small Molecule Drug Discovery product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Small Molecule Drug Discovery, with revenue, gross margin, and global market share of Small Molecule Drug Discovery from 2021 to 2026.
Chapter 3, the Small Molecule Drug Discovery competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Small Molecule Drug Discovery market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Small Molecule Drug Discovery.
Chapter 13, to describe Small Molecule Drug Discovery research findings and conclusion.
Summary:
Get latest Market Research Reports on Small Molecule Drug Discovery. Industry analysis & Market Report on Small Molecule Drug Discovery is a syndicated market report, published as Global Small Molecule Drug Discovery Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Small Molecule Drug Discovery market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.